Report : Europe Gastrointestinal Drugs Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Class (Acid Neutralizers, Antidiarrheal and Laxatives, Anti-Inflammatory Drugs, Antiemetic and Antinauseants, Biologics, and Others); Route of Administration (Oral, and Parenteral); Application (Inflammatory Ulcerative Colitis, Crohn's Disease, Irritable Bowel Syndrome, Gastroenteritis, Celiac Disease, and Others); and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Country

According to our new market research study on “Europe Gastrointestinal Drugs Market to 2027 – Regional Analysis and Forecast – by Drug Class, Route of Administration, Application, and Distribution Channel” the market is expected to reach US$ 17,810.81 million by 2027 from US$ 12,721.85 million in 2019; it is estimated to grow at a CAGR of 4.4% from 2020 to 2027. The report provides trends prevailing in the Europe gastrointestinal drugs market and the factors driving the market growth along with those hindering it.

In 2019, the acid neutralizers segment accounted for the highest share of the market. However, the biologics segment is expected to be the fastest-growing during the forecast period. The CAGR of the biologics segment accounted the highest CAGR in the forecast period. The growth of the segment is attributed to growing product development and increasing product launches in the market.

The growth of the Europe Gastrointestinal Drugs market is mainly attributed to rising prevalence of gastrointestinal (GI) diseases, and increase in development of biologics. However, side effects associated with the drugs will restrict the market growth.

Sanofi; GlaxoSmithKline plc; Johnson and Johnson Services, Inc.; AstraZeneca; and Bayer AG are among the leading companies operating in the Europe Gastrointestinal Drugs market.

The Report Segments Europe Gastrointestinal Drugs Market as Follows:

Europe Gastrointestinal Drugs Market – By Drug Class

  • Acid Neutralizers
  • Antidiarrheal and Laxatives
  • Anti-Inflammatory Drugs
  • Antiemetic and Antinauseants
  • Biologics
  • Others

Europe Gastrointestinal Drugs Market – By Route of Administration

  • Oral
  • Parenteral

Europe Gastrointestinal Drugs Market – By Application

  • Inflammatory Ulcerative Colitis
  • Crohn's Disease
  • Irritable Bowel Syndrome
  • Gastroenteritis
  • Celiac Disease
  • Others

Europe Gastrointestinal Drugs Market – By Country

  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876

Download Free PDF Brochure